Matthew Nelson Email & Phone Number

Matthew Nelson Work

• 2023 -now VP, FP and A @ Orbital Therapeutics (acquired by Bristol Myers Squibb in December 2025)
• 2023 -2023 Finance Consulting @ Consulting
• 2021 -2023 VP of Finance @ Finch Therapeutics
• 2019 -2021 Senior Director, Financial Planning and Analysis @ Finch Therapeutics
• 2019 -2019 Senior Director, Financial Planning and Analysis @ Casebia Therapeutics
• 2017 -2018 Director, Financial Planning and Analysis @ Casebia Therapeutics
• 2016 -2017 Director, Financial Planning and Analysis @ Inotek Pharmaceuticals Corporation
• 2016 -2016 Associate Director, Financial Planning and Analysis @ Aegerion Pharmaceuticals
• 2015 -2016 Senior Manager, Financial Planning and Analysis @ Aegerion Pharmaceuticals
• 2014 -2015 FP and A Business Development and Commercial Manager @ Aegerion Pharmaceuticals
• 2013 -2014 Financial Planning and Analysis Manager @ Aegerion Pharmaceuticals
• 2013 -2013 Manager, FP and A @ AVEO Oncology
  View Department
• 2011 -2012 Senior Financial Analyst – Strategic Alliances @ AVEO Oncology
• 2009 -2011 Principal Accountant, International Finance @ Sanofi
• 2007 -2009 Senior Accountant, International Finance @ Sanofi
  View Department
• 2006 -2007 Consolidations Analyst @ Sanofi
  View Department
• 2006 -2006 Accountant I @ Sanofi
  View Department
• 2004 -2006 Senior Client Account Manager @ Brown Brothers Harriman